Mar 16, 2021 Roth Capital Partners acted as Co-Manager for Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC) in its $14.5 Million Follow-On Offering Roth Capital Partners
Mar 15, 2021 Roth Capital Partners acted as Co-Manager for Marker Therapeutics, Inc. (Nasdaq: MRKR) in its $56.5 Million Follow-On Offering Roth Capital Partners
Mar 15, 2021 Roth Capital Partners acted as Sole Placement Agent for Assertio Holdings, Inc. (NASDAQ: ASRT) in its $14 Million and $34.3 Million Registered Direct Offerings Roth Capital Partners
Mar 12, 2021 Roth Capital Partners acted as Joint Book-Running Manager for Phunware, Inc. (NASDAQ: PHUN) in its $26.5 Million Follow-On Roth Capital Partners
Mar 10, 2021 Roth Capital Partners 33rd Annual Conference to be held Virtually March 15-17, 2021 InvestorWire
Feb 26, 2021 Roth Capital Partners advised Tengasco, Inc. (NYSE:TGC) on its Merger with Riley Exploration Permian, LLC Roth Capital Partners
Feb 18, 2021 Roth Capital Partners acted as Sole Placement Agent for Bio-Path Holdings, Inc., (Nasdaq:BPTH) in its $13 Million Follow-On Offering Roth Capital Partners
Feb 16, 2021 Roth Capital Partners acted as Sole Placement Agent for NewAge, Inc. (Nasdaq: NBEV) in its $58 Million Private Placement Roth Capital Partners
Feb 16, 2021 Roth Capital Partners acted as Co-Manager for KalVista Pharmaceuticals, Inc. (Nasdaq: KALV) in its $222.5 Million Follow-On Roth Capital Partners
Feb 16, 2021 Roth Capital Partners acted as Sole Placement Agent for InMed Pharmaceuticals Inc. (Nasdaq: INM) (TSX: IN) in its $4.5 Million PIPE Transaction Roth Capital Partners
